Optimising anticoagulation management in atrial fibrillation: focus on patients with concomitant ACS and/or undergoing PCI

Learning Objectives

To understand the current evidence and outstanding questions in managing atrial fibrillation patients with concomitant acute coronary syndrome (ACS) and/or undergoing PCI
To review the role of non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin for atrial fibrillation (AF) patients requiring anticoagulation and antiplatelet therapy
To discuss the optimal choice of antiplatelets in AF patients who develop acute coronary syndrome (ACS) and/or undergo PCI

Presentations available when logged in:

Session objectives
Advancing atrial fibrillation patient care: Achievements with non-vitamin K antagonist oral anticoagulants to date
Anticoagulation in atrial fibrillation patients with concomitant ACS: Current consensus and outstanding questions
AUGUSTUS: Exploring the use of apixaban in atrial fibrillation patients with ACS and/or undergoing PCI
AUGUSTUS: Is there still a role for aspirin in atrial fibrillation patients who develop ACS?
Session evaluation and key learnings

Your free My PCR account will enable you to: